TIDMABDX
RNS Number : 0295R
Abingdon Health PLC
24 October 2023
Abingdon Health plc
("Abingdon" or "the Company")
Award of Options under LTIP
York, U.K. 24 October 2023: Abingdon Health plc (AIM: ABDX), a
leading international developer and manufacturer of high quality,
rapid diagnostic tests, announces that, under the terms of the
existing Long Term Incentive Plan established in December 2022
("LTIP" or the "Plan"), the Company has awarded share options
("Options") over a total of 2,386,238 ordinary shares of 0.025
pence each ("Ordinary Shares") to certain directors and senior
management, in order to incentivise and encourage retention in a
manner that aligns with the interests of the Company's
shareholders.
The Options are nil cost and will vest over a three-year vesting
period. Vesting of the Options is conditional upon the business
achieving certain challenging revenue, adj. EBITDA and total
shareholder return criteria. The Options will become exercisable
between 24 October 2026 and 24 October 2033.
The following directors and members of the senior management
team (each a person discharging managerial responsibilities
("PDMR")) have been awarded options:
PDMR Role No. of new No. of existing Total number
Options awarded Options under of Options
under the the LTIP under the
LTIP LTIP
Chief Executive
Chris Yates Officer 850,459 1,285,714 2,136,173
Chris Hand Non-Executive Chairman 283,486 428,571 712,057
Chief Operating
Mark Jones Officer 401,376 600,000 1,001,376
Chief Technical
Nina Garrett Officer 337,156 515,000 852,156
Candice Vendetuolli Head of QARA 183,486 285,714 469,200
Natalie Thrush Head of HR 68,807 90,000 158,807
Head of Sales &
Liam Currivan Marketing 261,468 - 261,468
As a result of these changes, the Company now has outstanding
options over 5,719,162 Ordinary Shares equal to approximately 4.7
per cent. of the Company's issued share capital.
Enquiries:
Abingdon Health plc www.abingdonhealth.com/investors/
Chris Yates, Chief Executive Officer Via Walbrook PR
Chris Hand, Non-Executive Chairman
Singer Capital Markets (Sole Broker and Tel: +44 (0)20 7496 3000
Nominated Adviser)
Peter Steel, Alex Bond, Jalini Kalaravy
Walbrook PR Limited Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com
Paul McManus / Phillip Marriage Mob: +44 (0)7980 541 893 / +44 (0)7867
Alice Woodings 984 082
+44 (0)7407 804 654
About Abingdon Health plc
Abingdon Health is a leading lateral flow contract research
(CRO) and contract development and manufacturing organisation
("CDMO") offering its services to an international customer base
across industry sectors that include clinical, animal health, plant
health, and environmental testing. Abingdon Health has the internal
capabilities to take projects from initial concept through to
routine and large-scale manufacturing; from "idea to commercial
success."
The Company's CDMO division offers product development,
regulatory support, technology transfer and manufacturing services
for customers looking to develop new assays or transfer existing
laboratory-based assays to a lateral flow format. Abingdon Health
aims to support the increase in need for rapid results across many
industries and locations and produces lateral flow tests in areas
such as infectious disease, clinical testing including companion
diagnostics, animal health and environmental testing. Faster access
to results allows for rapid decision making, targeted intervention
and can support better outcomes.
Abingdon Health's Abingdon Simply Test (TM) range of self-tests
is an ecommerce platform that offers a range of self-tests to
empowers consumers to manage their own health and wellbeing. The
Abingdon Simply Test (TM) ecommerce site offers consumers a range
of information to support them in making informed decisions on the
tests available. In addition, the site provides Abingdon's contract
services customers with a potential route to market for self-tests.
The Abingdon Simply Test range is also sold through international
distributors and through other channels in the UK and Ireland such
as pharmacy chains.
Founded in 2008, Abingdon Health is headquartered in York,
England.
For more information visit: www.abingdonhealth.com
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Chris Yates
Reason for the notification
2
a) Position/status Chief Executive Officer
b) Initial notification Initial notification
/Amendment
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of the Ordinary Shares of 0.025 pence each
financial instrument,
type of instrument
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil-cost 850,459
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Dr Chris Hand
Reason for the notification
2
a) Position/status Non-Executive Chairman
b) Initial notification Initial notification
/Amendment
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of the Ordinary Shares of 0.025 pence each
financial instrument,
type of instrument
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 283,486
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Mark Jones
Reason for the notification
2
a) Position/status Chief Operating Officer
b) Initial notification Initial notification
/Amendment
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of the Ordinary Shares of 0.025 pence each
financial instrument,
type of instrument
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 401,376
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Nina Garrett
Reason for the notification
2
a) Position/status Chief Technical Officer
b) Initial notification Initial notification
/Amendment
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of the Ordinary Shares of 0.025 pence each
financial instrument,
type of instrument
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 337,156
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Candice Vendetuolli
Reason for the notification
2
a) Position/status Head of QARA
b) Initial notification Initial notification
/Amendment
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of the Ordinary Shares of 0.025 pence each
financial instrument,
type of instrument
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 183,486
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Natalie Thrush
Reason for the notification
2
a) Position/status Head of HR
b) Initial notification Initial notification
/Amendment
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of the Ordinary Shares of 0.025 pence each
financial instrument,
type of instrument
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 68,807
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Liam Currivan
Reason for the notification
2
a) Position/status Head of Sales & Marketing
b) Initial notification Initial notification
/Amendment
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
a) Name Abingdon Health plc
b) LEI 213800XFI4WV3FBILO20
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of the Ordinary Shares of 0.025 pence each
financial instrument,
type of instrument
Identification code GB00BLF79J41
b) Nature of the transaction Award of LTIP Options
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 261,468
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
e) Date of the transaction 23(rd) October 2023
f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHMZMZGGFVGFZZ
(END) Dow Jones Newswires
October 24, 2023 02:05 ET (06:05 GMT)
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Apr 2024 to May 2024
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From May 2023 to May 2024
